Thanks for responding Stweeve and Anyones Guess.My last post got...

Thanks for responding Stweeve and Anyones Guess.
My last post got cut off on the right-hand-side
losing some of it's meaning. I will have to write
shorter lines!

Here are three more quotes from 20 Feb 14
Investor Presentation.

•40 sites in Australia used for “in market” 
product development, commercialisation
and early sales

•US Distribution commencing by Medline
in Q1 14
(Medline have 1100 sales reps and 37
distribution centres and we are now in Q1 2014)

•Global distribution discussions advancing
  in Canada and the EU

It's a commercialised product with FDA clearance,
a strong patent and no competition.

Wouldn't this indicate early market acceptance
in Australia?
Would Medline take the product on if they weren't
sure there was a ready market in the US?

I took a small position this morning.
I see this as a buy and hold stock which can get
a rocket underneath it as news of US, Canada and EU
sales start to come through.

I had first-hand experience with the whole
incontinence issue whilst caring for my father-in-law
most of last year before his death in December.
It's an enormous problem in hospitals and
nursing homes and Simavita have a solution.